Parkinson's Disease
Clinical guidelines for managing neurodegeneration and improving quality of life.
Table of Contents
🧠 Standard of Care
Parkinson's disease (PD) treatment is highly individualized. Management typically involves a combination of prescription medications to manage motor symptoms and intensive lifestyle adjustments.
- Movement Disorder Specialists: Care should ideally be overseen by a neurologist specializing in movement disorders.
- Physical Exercise: Regular, intensive exercise (like Tai Chi, cycling, or boxing) is the only intervention strongly correlated with slowing physical decline.
- Medication Timing: PD medications are "time-critical." Skipping or delaying doses can lead to severe physical freezing ("off" periods).
💊 Prescribed Medications
Most medications work to replenish or mimic dopamine in the brain.
Carbidopa-Levodopa
The gold standard. Levodopa converts to dopamine in the brain. Carbidopa prevents the premature breakdown of Levodopa in the bloodstream, severely reducing nausea side effects.
Dopamine Agonists (Pramipexole, Ropinirole)
These drugs directly mimic the effects of dopamine and are often used as an alternative or alongside Levodopa to smooth out "off" periods.
MAO-B & COMT Inhibitors
These medications prevent the enzymatic breakdown of naturally occurring dopamine or administered Levodopa, prolonging symptom relief.
🌿 Over-The-Counter (OTC) Therapies
Many patients explore OTC supplements, but evidence is heavily lacking.
- Coenzyme Q10 (CoQ10) & Vitamin E: Frequently discussed for neuroprotection, but large-scale clinical trials have failed to prove efficacy.
- Mucuna Pruriens: A natural source of Levodopa. However, it is unregulated, making precise dosing impossible.
🔬 Clinical Trials
Clinical trials are constantly recruiting to find a cure and better management tools.
Types of Trials Currently Recruiting
- Disease-Modifying Therapies: Drugs targeting specific genetic mutations (like LRRK2 or GBA) to fundamentally slow disease progression.
- Deep Brain Stimulation (DBS): Testing refined, adaptive pacemakers for the brain to halt tremors.
- Biomarker Studies (e.g., PPMI): Observational studies analyzing skin or blood samples to identify how PD starts before motor symptoms appear.
Get Updates on Research & Tools
Sign up to receive the latest open-source models, datasets, and literature updates for this condition.